Main Library
February 26, 2026 – Long-term care is becoming a care concept rather than a care setting. It’s another node in the care ecosystem where medication intelligence is the connective tissue and a critical success factor for home-based care.
If you mention long-term care (LTC), most people think of nursing homes – brick and mortar facilities where frail seniors go to live out the remainder of their lives when family and friends are no longer able to manage and/or afford their care at home. For a long time, the industry has viewed the LTC segment as a mature market dominated by Medicaid, plagued by staff shortages, with extreme pricing pressure and limited potential for growth.
It’s true that according to CMS certified facility counts from 2015 to 2025 there has been a modest, long run decline in the number of nursing homes from approximately 15M to 14.7M, while licensed beds have remained static for over a decade at 1.6 M. This includes the Covid years that caused a precipitous drop in occupied beds, causing some facilities to close and that has only partially rebounded to about 77% today.